Clinical data | |
---|---|
Trade names | Visken, others[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684032 |
Pregnancy category |
|
Routes of administration | By mouth, intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 50% to 95% |
Metabolism | Hepatic |
Elimination half-life | 3–4 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.033.501 |
Chemical and physical data | |
Formula | C14H20N2O2 |
Molar mass | 248.326 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Pindolol, sold under the brand name Visken among others, is a nonselective beta blocker which is used in the treatment of hypertension.[1][2] It is also an antagonist of the serotonin 5-HT1A receptor, preferentially blocking inhibitory 5-HT1A autoreceptors, and has been researched as an add-on therapy to various antidepressants, such as clomipramine and the selective serotonin reuptake inhibitors (SSRIs), in the treatment of depression[3][4][5] and obsessive-compulsive disorder.[6][7]
pmid9635544
was invoked but never defined (see the help page).pmid23757185
was invoked but never defined (see the help page).pmid25689398
was invoked but never defined (see the help page).